Bosnia na Hezegovina - Kroeshia - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - ibandronska kiselina - film tableta - 150 mg/1 tableta - 1 film tableta sadrži: 150 mg ibandronske kiseline (u obliku ibandronatnatrijum monohidrata)

Bosnia na Hezegovina - Kroeshia - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

medicopharmacia d.o.o. sarajevo - ibandronska kiselina - film tableta - 50 mg/1 tableta - 1 film tableta sadrži: 50 mg ibandronska kiselina (u obliku ibandronatnatrijum, monohidrata)

Bosnia na Hezegovina - Kroeshia - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pliva d.o.o.sarajevo - ibandronska kiselina - filmom obložena tableta - 150 mg/1 tableta - 1 filmom obložena tableta sadrži: 150 mg ibandronske kiseline (u obliku ibandronatnatrijum, monohidrata)

Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfom, mantel-stanica - antineoplastična sredstva - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

gilead sciences ireland uc - Софосбувир, velpatasvir - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 i 5.

Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

gilead sciences ireland uc - ледипасвир, софосбувир - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 i 5. virus hepatitisa c (hcv) genotip-specifične aktivnosti vidi 4. 4 i 5.

Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing limited - mcloksikam - oxicams, anti-inflammatory and anti-rheumatic products, non-steroids - dogs; horses; cats; cattle; pigs - dogsalleviation upale i bolova u akutni i kronični mišićno-koštanog sustava u pasa. da bi se smanjila sobu za intenzivnu njegu bol i upalu nakon ortopedskih i operacije mekih tkiva. catsreduction postoperativni bol nakon овариогистерэктомии i male operacije mekih tkiva . ublažavanje blage do umjerene postoperativni bol i upale nakon kirurške intervencije kod mačaka, e. ortoza i operacije mekih tkiva . olakšanje boli i upale kod akutne i kronične bolesti mišićno-koštanog sustava kod mačaka. koristiti cattlefor prilikom akutne infekcije respiratornog odgovarajuće antibiotske terapije za smanjenje kliničkih znakova. za korištenje kod proljeva u kombinaciji s oralnu регидрационной terapija za smanjenje kliničkih znakova kod teladi u roku od jednog tjedna, u dobi i mladi, ne-mliječne krave. za pomoćnu terapiju u liječenju akutnog mastitisa, u kombinaciji s antibiotskom terapijom. koristiti pigsfor u неинфекционной bolestima mišićno-koštanog sustava za ublažavanje simptoma hromost i upale. za pomoćnu terapiju u liječenju puerperalne septikemije i toksemije (mastitis-metritis-agalaktia sindrom) s odgovarajućom terapijom antibioticima. za olakšanje postoperativne boli povezane s manjim mekim tkivom kao što je kastracija. horsesalleviation upale i olakšavanja boli u akutni i kronični mišićno-koštanog sustava kod konja. za olakšanje boli povezane s kolikom kolica.

Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

gilead sciences ireland uc - Софосбувир, velpatasvir, voxilaprevi - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (vidi 4. 2, 4. 4 i 5.

Umoja wa Ulaya - Kroeshia - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 i 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 i 5.